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Intraoperative C-arm cone-beam computed
tomography in fenestrated/branched aortic
endografting
Martijn L. Dijkstra, BA,a Matthew J. Eagleton, MD,a,b Roy K. Greenberg, MD,a,b
Tara Mastracci, MD,a and Adrian Hernandez, MD, PhD,c Cleveland, Ohio
Objectives: To evaluate the use of intraoperative guidance by means of C-arm cone-beam computed tomography (CT)
(cone-beam computed tomography [CBCT]) and the use of postoperative CBCT to assess for successful aneurysm
exclusion in fenestrated branched endovascular aneurysm repair (FEVAR).
Methods: Patients with FEVAR who underwent CBCT were retrospectively evaluated and categorized into one of two
groups. The CBCT-fusion group was comprised of patients who underwent preprocedural CBCT to guide FEVAR using
fusion imaging with multidetector computed tomography (MDCT). The postprocedure CBCT group consisted of
patients undergoing CBCT following deployment of the endograft. Outcomes from the CBCT-fusion group were
compared with historical controls. These controls were patients who underwent FEVAR for similar groups of abdominal
and thoracoabdominal aortic aneurysms in the 12 months preceding the initiation of a CBCT program. The findings on
postprocedural CBCTwere compared with those on predischarge MDCT. Results are expressed as meanstandard error
of the mean, or as median and interquartile range.
Results: Forty patients were included in the “CBCT-fusion” group and compared with the historical cohort. The use of
perioperative guidance of FEVAR by means of CBCT resulted in a significantly lower contrast dose (94 cc [72-131] vs
136 cc [96-199]; P  .001). While there was a trend toward lower operative (330 minutes [273-522] vs 387 minutes
[290-477]; P .651) and fluoroscopy times (81min [54-118] vs 90minutes (46-128), P .932); this difference did not
reach statistical significance. Nineteen patients were included in the “postprocedural CBCT” group and compared with
predischarge MDCT. Postoperative CBCT identified eight endoleaks. Type I and III (n  6) endoleaks were identified
and treated during the primary procedure. When CBCT did not show an endoleak, this was confirmed by MDCT. The
use of CBCT required significantly less contrast compared toMDCT (50 cc [set amount] vs 100 cc [80-125]; P< .0001).
Mean skin dose was 0.27 (0.011) Gy for preoperative CBCT and 0.552 (0.036) Gy for postoperative CBCT.
Conclusions:CBCT is a valuable addition to complicated aortic interventions such as FEVAR. Intraoperative use utilizing
fusion imaging limits contrast dosage and postdeployment CBCT is of sufficient quality to evaluate successful aneurysm
exclusion and for detection of early complications after FEVAR. With the information we are able to obtain from the
CBCT at the completion of the FEVAR, we can intervene on problems earlier and potentially decrease the subsequent
need for reintervention. (J Vasc Surg 2011;53:583-90.)
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mEndovascular technology has evolved at a rapid rate,
allowing for the treatment of more complex diseases. The
endovascular treatment of complex aortic disease relies
heavily on a combination of imaging modalities, but pre-
and postoperative computed tomography (CT) and intra-
operative fluoroscopy remain the two most widely used
radiologic tools. CT provides detailed morphologic infor-
mation about the aorta, which allows for accurate preoper-
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doi:10.1016/j.jvs.2010.09.039tive planning and postoperative surveillance. While the
omplexity of the procedures increases, such as with the
evelopment of fenestrated/branched endovascular aneu-
ysm repair (FEVAR), the ability to more accurately evalu-
te the three-dimensional (3D) architecture of the aortic
ree before, during, and after surgery becomes increasingly
mportant. While the use of multidetector computed to-
ography (MDCT) has allowed for the 3D imaging of
hese arterial structures in the pre- and postoperative pe-
iod, intraoperative arterial assessment has historically been
imited to two-dimensional (2D) angiography and fluoros-
opy. Flat panel detectors (FPD) have begun to replace the
tandard imager intensifiers used on conventional fluoros-
opy units. The application of FPD has provided the ability
o perform intraoperative 3D imaging using rotational
ngiography. C-arm cone-beam computed tomography
CBCT) is an advanced imaging capability that uses C-arm
at panel fluoroscopy systems to acquire and display 3D
mages. The FPD functions much like the multiline detec-
ors used in MDCT and provides “CT-like” images in
ultiple viewing planes. CBCT systems are now commer-
ially available and each manufacturer has its own imaging
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March 2011584 Dijkstra et alprotocol that is tailored to each system’s different rotation
time, number of projections acquired, image quality, and
time required for reconstruction.
There are at least three potential applications of CBCT
in aortic endografting including its use for preprocedure
anatomic assessment and stent-graft sizing,1-3 fusion imag-
ing to guide device implantation, and postprocedural as-
sessment of successful aneurysm exclusion. Preliminary ex-
perience has demonstrated its potential utility in pre- and
postdeployment scenarios.1-5 One of the most potentially
useful applications of CBCT is intraoperatively to guide the
performance of fluoroscopy-driven procedures using fusion
of CT images and fluoroscopy, similar to traditional “road-
mapping.” Intraoperative CBCT images can be registered,
or fused, with preoperative MDCT allowing the MDCT
image to be superimposed on the live fluoroscopic image.
The superimposed image will then update in the correct
projection depending on the arc angle of the C-arm. There
is little information about the usefulness of this technology
in the treatment of aortic aneurysms or complex aortic
disease. It has been shown, however, to accurately outline
the coronary sinus anatomy and assist in guiding cardiac
resynchronization therapy placement, which relies heavily
on understanding the 3D structure of the heart.6
The aim of this study is to evaluate our initial experi-
ence using CBCT during FEVAR. CBCT is currently not
sophisticated enough to allow for preoperative planning
and sizing for FEVAR. This study will assess our initial
experience with two other applications of CBCT: (1) the
intraoperative use of CBCT to direct placement of fenes-
trated/branched endografts; and (2) the postdeployment
use of CBCT to assess for the adequacy of endograft
exclusion of the aortic aneurysm.
METHODS
All patients who underwent FEVAR between August
2009 and March 2010 were retrospectively evaluated. FE-
Fig 1. Images depicting the fusion of the cone-beam co
introduction. The colored images represent those of the
while the gray-scale images are the ones obtained from th
(A) axial, (B) anterior, and lateral (not shown). Once the s
the MDCT can be overlaid on the live fluoroscopic imagVAR was performed as part of an investigational device txemption protocol. Written informed consent was ob-
ained from all patients and the study was approved by the
nstitutional Review Board (IRB # 4281). Patients in
hom CBCT was performed were reviewed and catego-
ized into one of two groups. The “CBCT-fusion” group
as comprised of patients who underwent predeployment
BCT and fusion of this image with a preoperative MDCT
o guide placement of the fenestrated graft. The “postpro-
edural CBCT” group contained patients in whom CBCT
as performed postdeployment to assess the effectiveness
f aneurysm exclusion and maintenance of branch patency.
CBCT was performed at the Cleveland Clinic since Au-
ust 2009. Scans were performed on Artis zeego with syngo
ynaCT (Siemens Healthcare, Forchheim, Germany) at the
iscretion of the operating surgeon using standardized proto-
ols. The decision to perform CBCT was dependent on mul-
iple factors including total radiation and contrast dose used
uring the primary procedure and baseline renal function.
xcluded from both cohorts were patients who underwent
EVAR for type II thoracoabdominal aneurysms (TAAAs)
nd those patients undergoing staged endovascular proce-
ures. Predischarge contrast-enhanced MDCT scanning was
outinely performed for patients following FEVAR as part of
he investigational device exemption study protocol. Patients
ho did not have a predischarge MDCT scan were excluded
rom the “postprocedural CBCT” group analysis. Patient
emographics, operative data, and follow-up data were ex-
racted from the medical records.
CBCT fusion. This cohort entailed patients who used
redeployment CBCT fusion with preoperatively per-
ormed MDCT to direct FEVAR placement. Predeploy-
ent CBCT was performed using a 5sDR or an 8sDR
rotocol. The 5sDR protocol has a 5-second acquisition
ime capturing 133 frames at 30 frames/second (f/s)
here the 8sDR takes 8 seconds with 397 frames at 60 f/s.
ypically, bony structures and areas of heavy calcification
dentified on the CBCT were used as landmarks to “fuse”
ted tomography (CBCT) performed prior to stent graft
erative multidetector computed tomography (MDCT),
CT. The images are aligned in multiple planes including
re registered, or fused, with each other, the images frommpu
preop
e CB
cans ahe CBCT image with the MDCT (Fig 1). In case of a
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Volume 53, Number 3 Dijkstra et al 585heavily calcified aorta, or a stent graft in situ, the 5sDR
protocol is sufficient for adequate registration to MDCT.
In all other cases, the 8sDR allowed registration by means
of soft tissue landmarks. The MDCT image can then be
seen overlying the fluoroscopy image (Fig 2). Alternately,
after adequate registration, the system automatically graph-
ically outlines the aorta, and the ostia of the target vessels
are identified and manually encircled in the MDCT dataset
(Fig 3). These graphics are then overlaid and displayed live on
the in-suite monitors (Fig 3). The system adjusts the overlay
according to C-arm and table positions, making the location
of the target vessel ostia and the outline of the aorta visible
throughout the procedure. In this setting, predeployment
aortography was not performed. FEVAR was performed
based on the fusion imaging.
To assess whether the use of fusion technology altered
early outcomes of FEVAR, results from this initial cohort
were compared with outcomes from historical controls.
The historical cohort was collected from patients undergo-
ing FEVAR at the Cleveland Clinics in the 12 months prior
to initiation of CBCT. These included all patients under-
going FEVAR with the exception of patients undergoing
treatment for a type II TAAA. Demographics, operative
details, and outcomes were compared between the two
groups.
Postprocedural CBCT. The postprocedural CBCT
Fig 2. Example of an image that has been fused with th
cone-beam computed tomography (CBCT) are fused
tomography (MDCT). The baseline aortic morphology (
image can either be the image of the aorta (as seen in Fig
Note the location of the branches and the ostia of these b
is fused with a three-dimensional (3D) orientation, and a
change accordingly.group included patients in whom a completion CBCT was oerformed to assess the adequacy of repair. Postprocedural
mages were acquired using the 8sDSA protocol. Two
omplete runs are acquired including a native and a contrast
un. The contrasted run required an injection rate of 10 cc
er second for a total of 10 seconds. Fifty percent dilute
ontrast (Visipaque; GE Healthcare, Buckinghamshire,
K) was used routinely for a total of 50 cc of contrast per
un.
After acquisition, the data were automatically sent to
he Syngo X-Workplace (Siemens Healthcare) and recon-
tructed to 3D datasets. CBCT images were reviewed by
he operator and the main investigator in 2D side-by-side
iewing, native vs contrast-injected images, and dedicated
D postprocessing reconstructions (Fig 4) were developed
nd reviewed to optimize sensitivity and specificity. Re-
iewing was done using the Aquarius Workstation (Tera-
econ, San Mateo, Calif). CBCT and MDCT were
valuated for endoleaks, stent graft integrity, vessel pa-
ency, and aortic diameter measurements. Attenuation
Hounsfield unit [HU]) measurements of the stent graft
umen, aneurysm sac, and contrast extravasation (endoleak)
f present were assessed. Results from postprocedural
BCT were compared with those on the predischarge
DCT.
Statistical analysis. Data analysis was performed us-
ng SPSS statistics 17.0 (SPSS Inc, Chicago, Ill). Continu-
e fluoroscopy-obtained image. The images obtained on
those of the preoperative multidetector computed
n then be depicted on the live fluoroscopy. The overlay
el A) or a computer-generated outline of the aorta (B).
es, which are represented by circles (arrows). The image
-arm arc rotates, the orientation of the fused image wille liv
with
A) ca
3, pan
ranch
s the Cus variables are described as mean and standard deviation
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March 2011586 Dijkstra et alor median and interquartile range (IQR) in case of skewed
data. Differences between continuous variables were tested
using independent t test for pre-CBCT vs historical cohort
and paired t test or the Wilcoxon rank-sum test (if n 30)
for post-CBCT vs MDCT. Categorical variables were
tested using Pearson 2 test or the Fisher exact test (if n 
5). Two-sided P values .05 were considered significant.
Radiation dosage for CBCT is noted as skin-absorbed dose
expressed in mGy. Radiation dosage for MDCT is noted as
dose length product expressed in Gycm.
RESULTS
A total of 82 patients who underwent FEVAR were
reviewed. In 40 patients, CBCT fusion was performed, 19
patients underwent a postprocedural CBCT, and eight
patients underwent both. In the remaining 23 patients, no
CBCT was performed, and they were excluded from fur-
ther analysis.
CBCT fusion. Demographics and operations per-
formed were similar between the CBCT fusion group (n
40) and the historical controls (n  49) (Table I). Median
follow-up was 2 (1.3-4.0) months for the CBCT fusion
group compared and 10 (8.0-14.5) months for the histor-
ical controls. All but one preoperative-acquired CBCT
proved of sufficient quality for adequate image overlay
(39/40 [98%]). The 5sDR protocol was used in eight
(20%) cases, and the 8sDR protocol in 32 (80%) cases.
Fig 3. Image obtained from intraoperative fluoroscopy
of the aorta (color) overlaid on the fluoroscopy image (A
These are used to direct catheters and wires into the target
the catheter (arrow) and wire (double arrow) that are
computer-generated graphic image of the aorta can be d
and computer-generated image are linked in a three-dim
C-arm. Again, note the catheters and wires that are prese
the left renal artery do not follow the exact path of the v
technology in that while it can accommodate for rotation
the arterial tree.Median radiation dose was 0.18 Gy (0.11-0.25) for the esDR protocol and 0.29 Gy (0.27-0.31) for the 8sDR
rotocol. Median contrast dose was 94 cc for the CBCT
usion group compared to 136 cc in the historical cohort
P  .001) (Table II). There was a trend toward lower
perative times and fluoroscopy times in the CBCT fusion
roup, but this did not reach statistical significance (Table II).
Technical success was defined as successful deployment
f the endograft with stenting of all the target vessels. The
rocedure was technically successful in 84.8% of the cases in
he CBCT fusion group, compared with 89.8% in the
istorical cohort (P .98). In the CBCT group, there were
our (10%) cases in which one of the target vessels could not
e cannulated (two renal arteries, one celiac artery, and one
ypogastric artery) and thus were not stented. All visceral
essels were successfully stented at a follow-up procedure,
nd the hypogastric artery ultimately occluded and was left
ntreated. Early endoleak rates, detected on 1-month fol-
ow-up MDCT, did not differ in the CBCT fusion group (7
17.5%] type II and 1 [2.5%] type III (endoleaks) compared
o the historic control group (3 [6.1%] type I, 3 [6.1%] type II,
nd 4 [8.2%] type III endoleaks).
Postprocedural CBCT. A total of 19 patients under-
ent evaluation by postdeployment CBCT. In this series,
wo infrarenal, four juxtarenal, and eight thoracoabdomi-
al aneurysms underwent primary endovascular repair. In
he remaining five cases, diagnostic imaging by means of
BCT was performed prior to treatment for a known
multidetector computed tomography (MDCT) images
e yellow circles represent the ostia of the visceral vessels.
ls during the placement of a fenestrated endograft. Note
n the highlighted left renal artery. B, Alternatively, a
ed on the live fluoroscopy image. Both the actual image
nal (3D) setting and will rotate with revolution of the
the visceral vessels. Notice that the catheter and wire in
. This represents one of the potential limitations of this
e C-arm, it cannot account for the in vivo movement ofwith
). Th
vesse
withi
isplay
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nt in
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of thndoleak after FEVAR.
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Volume 53, Number 3 Dijkstra et al 587A total of 8 (36.8%) endoleaks were found on postpro-
cedural CBCT. Endoleaks were easily discernable. The
stent lumen was found to have a mean attenuation value of
583.4 58.6 HU. Contrast extravasation in the aneurysm
sac measured a mean attenuation 319  20.8 HU com-
pared with a mean attenuation 72.2  44.5 HU for aneu-
rysm sac without contrast extravasation, making endoleaks
clearly visible (Fig 4). CBCT demonstrated two (10.5%)
type I endoleaks. One originated from the right common
iliac artery and the second case was a proximal type I
endoleak. In both cases, the endoleaks were successfully
treated with a limb extension and a proximal cuff, respec-
tively. Four type III (21.1%) endoleaks were found (Fig 4).
Three originated from a renal artery branch, and one orig-
inated from a superior mesenteric artery (SMA) branch. All
cases were successfully treated with either reangioplasty
(n  3) or placement of another stent (n  1). Two
Fig 4. Demonstration of endoleaks identified on cone-
detector computed tomography (MDCT). A, CBCT ima
following fenestrated/branched endovascular aneurysm
branch that provides continued flow into the aortic s
endoleaks (B, C, and D). B, demonstrates type III
reconstructions (C) demonstrate continued flow in the
aneurysm sac and within the aortic graft itself. Alternate
can demonstrate the origin of an endoleak that is difficu
demonstrating the origin of the type III endoleak arising
E, For comparison, MDCT axial cross-section image o
FEVAR. Note that there is better visualization of the sof(10.5%) type II endoleaks from single lumbar arteries were Miagnosed and left untreated. When there were no en-
oleaks visible on CBCT, this was confirmed by MDCT.
here were no endoleaks found on MDCT that were not
isible on CBCT. One type II endoleak found on CBCT
as not visualized by the predischarge MDCT. No stent
ractures were noted and all incorporated vessels were pat-
nt on CBCT, which correlated to MDCT findings. Diam-
ter measurements obtained by CBCT were the same as
hose obtained on MDCT. All images had metal artifacts
rom the stent graft and guidewires in situ. These included
wo (10.5%) stripe artifacts and two (10.5%) calibration
rror artifacts. The latter arose from misalignment of the
etector after it was accidentally dislodged. No movement
rtifacts were observed.
Median radiation dose for the whole procedure was
.81 Gy (IQR 2.18-5.44). Postoperative CBCT contrib-
ted a median radiation dose of 0.55  0.036 Gy. For
computed tomography (CBCT) and follow-up multi-
entifying the presence of a type II endoleak immediately
ir (FEVAR). The arrow demonstrates a patent lumbar
ages demonstrating CBCT identification of type III
eak arising from the left renal artery (arrows). Axial
rysm sac. Note the ability to calculate HU within the
of view (D), similar to that obtained with MDCT (E),
identify on conventional angiography. Note the arrow
the superior mesenteric artery (SMA) branch (arrow).
pe III endoleak arising from a SMA branch following
es in the MDCT compared with CBCT.beam
ge id
repa
ac. Im
endol
aneu
fields
lt to
from
f a tyDCT, mean radiation dose was 2.56  0.76 Gy/cm2.
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March 2011588 Dijkstra et alContrast dose for CBCT was 50 cc (set amount) compared
to median contrast dose of 100 cc (80-125) for MDCT
(P  .0001).
DISCUSSION
Endovascular technology is rapidly advancing, allowing
for the treatment of more complex disease processes such as
complex aortic aneurysmal disease. Corresponding with
these advancements is the need for improved intraoperative
imaging capabilities that will allow the successful execution
Table I. Demographic and operative characteristics of the
CBCT
Total 4
Demographics
Gender
Male 34 (
Female 6 (
Age (mean [SD]) 74.1 (
BMI (mean [SD]) 28.3 (
Diabetes 6 (
Hypercholesterolemia 34 (
Carotid artery disease 6 (
Current smoker 7 (
Family history of aortic aneurysm 3 (
Coronary artery disease 24 (
Renal insufficiency 10 (
Pulmonary disease 13 (
ASA classification
3 22 (
4 18 (
Aneurysm anatomy
Juxtarenal 8 (
Thoracoabdominal 32 (
Number of fenestrations
1 1 (
2 2 (
3 19 (
4 18 (
Helical branch
No 33 (
Visceral 3 (
Hypogastric 4 (
BMI, Body mass index; CBCT, cone-beam computed tomography.
Data are presented as N (%) unless otherwise stated.
Table II. Operative data from CBCT fusion and historica
Fluoro time (minutes) Median (IQR)
Contrast dose (cc) Median (IQR)
Radiation dose (mGy) Median (IQR)
Operative time (minutes) Median (IQR)
Technical success N (%)
Failure to cannulate celiac N (%)
SMA N (%)
Right renal artery N (%)
Left renal artery N (%)
Hypogastric artery N (%)
CBCT, Cone-beam computed tomography; SMA, superior mesenteric arterof these procedures. The advent of FPDs and development af CBCT is a significant step forward in this process. As
maging systems at many centers are updated, this technol-
gy will become increasingly available. Given this, it is
mperative that practitioners become familiar with these
echnologies and their potential applications.
To date, little research has been presented regarding
he application of CBCT during abdominal aortic interven-
ions. This preliminary evaluation demonstrates that the
se of intraoperative CBCT to guide deployment of fenes-
rated endografts results in significantly lower contrast dos-
T fusion group and the historical controls
n Historical control P value
49 —
.628
) 37 (75.5%)
) 12 (24.5%)
74.6 (7.0) .508
28.5 (4.3) .625
) 8 (16.3%) .864
46 (93.9%) .167
7 (16.3%) .924
) 6 (12.2%) .485
11 (22.4%) .054
) 7 (16.3%) .117
11 (22.4%) .778
) 20 (40.8%) .419
.223
) 33 (69.3%)
16 (32.7%)
.779
) 11 (22.4%)
38 (77.6%)
.683
0 (0.0%)
4 (8.2%)
) 25 (51.0%)
) 20 (40.8%)
.602
) 44 (89.8%)
2 (4.1%)
) 3 (6.1%)
trol groups
CBCT fusion Historical control P value
81 (54-118) 90 (46-128) .932
94 (72-131) 136 (96-199) .001
7 (4-12) 7 (5-10) .782
30 (273-522) 387 (290-477) .651
28 (85) 44 (90) .975
1 (2.5) 1 (2.0)
0 (0.0) 2 (4.1)
2 (5.0) 2 (4.1)
0 (0.0) 0 (0.0)
1 (2.5) 0 (0.0)CBC
fusio
0
85.0%
15.0%
9.5) y
5.1)
15.0%
85%)
15%)
17.5%
7.5%)
60.6%
25%)
32.5%
55.0%
45%)
20.0%
80%)
2.5%)
5.0%)
47.5%
45.0%
82.5%
7.5%)
10.0%l con
3ge (P .001), with a trend toward lower fluoroscopy and
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Volume 53, Number 3 Dijkstra et al 589total operative times. Certainly, based on this data, one
could call into question the significance of this technology,
as the only significant difference was a 40-cc reduction in
contrast use. In the authors’ opinion, however, the findings
are extremely important. There is evidence to suggest that
repeated doses of contrast agent may contribute to the
development of lifelong nephrotoxicity.7 In addition, the
application of this technology was limited to patients that
did not have the need for more complicated fenestrated/
branched endograft placement, and few of the patients had
significant renal impairment. This was at the discretion of
the operating surgeons and represents self-imposed limita-
tions during the initial application of this technology. Pa-
tients requiring aortic interventions, however, are not with-
out significant contrast-associated risks due to the presence
of pre-existing renal insufficiency.8 All efforts to reduce the
use of contrast agents to the lowest dose that will allow
successful performance of the procedure should be em-
ployed. With growing experience with this technology, the
authors have found the use of CBCT-guided deployment
of fenestrated/branched endografts invaluable, particularly
in very complex anatomy and in patients with renal insuffi-
ciency. In fact, since the analysis of the analysis of these
initial outcomes, the use of CBCT in this manner has been
liberalized and the deployment of fenestrated/branched
endografts has been performed using as little as 10 cc of
contrast in patients with significant renal impairment. We
suspect that on later analysis, as the experience grows, we
will see an additional reduction in fluoroscopy and opera-
tive times as well.
Postoperative CBCT provides an image quality suffi-
cient for evaluating successful aneurysm exclusion and as-
sessment of complications following endovascular aneu-
rysm repair. One of the difficulties in assessing adequacy of
treatment with FEVAR using completion angiography is
determining the potential source of endoleaks. Typically, if
the source of an endoleak is not discernable by conven-
tional angiography, it can be identified on follow-up
MDCT. This requires, however, return to the operating
room for a secondary intervention in the postoperative
period.9 As described above, and by others,4,5 postdeploy-
ment CBCT allows for the immediate recognition of the
endoleak source, with greater detail than can be provided
by angiography and subsequent treatment during the initial
surgery. In fact, case reports have been published showing
CBCT is able to detect an endoleak where angiography fails
to do so.4,5 We did not perform completion angiography in
conjunction with completion CBCT to avoid the addi-
tional radiation and contrast loads. As such, direct compar-
ison of sensitivity and specificity of endoleak identification
between angiography and CBCT is not possible. It was
noted, however, that when no abnormality was identified
on CBCT, none was visualized on MDCT. With increased
application of this technology, however, we will be able to
more effectively evaluate the rate of subsequent reinterven-
tions to determine whether this is reduced by the use of
CBCT. One limitation, however, may be in the identifica-
tion of type II endoleaks. In one case, CBCT identified a mype II endoleak, which was not visible on the predischarge
DCT. There are multiple explanations for this finding
ncluding resolution of the endoleak prior to follow-up
DCT. Alternatively, MDCT failed to show the endoleak
ue to the fact that these scans are made on fixed times.
BCT acquisition is done during continuous contrast in-
ection, allowing for uninterrupted evaluation of early arte-
ial to venous phase images, not only demonstrating where
he endoleaks might originate, but also when they do.
In addition, postdeployment CBCT proved to be ade-
uate for assessment of incorporated vessel patency and
tent graft integrity. As has been previously demonstrated
hat diameter measurements onCBCT andMDCT showed
omparable outcomes,3,10 results from this study support
hese findings. While not applicable to current fenestrated
ndografting, this technology may prove useful in the
n-table planning and sizing of patients undergoing endo-
ascular aneurysm repair (EVAR),1,2 particularly in the
etting of ruptured abdominal aortic aneurysms. In addi-
ion, while this study was limited to the deployment of
enestrated endografts, the technology, both to guide de-
loyment and to assess adequacy of aneurysm exclusion,
an easily be applied successfully to the performance of
lective EVAR and thoracic aortic endograft placement. In
ddition to using this imaging modality to plan and size for
VAR or thoracic endovascular aneurysm repair, the fusion
echnology can be used to more accurately deploy the graft
ear important branch vessels—without the use of contrast.
n addition, it can be used to immediately assess the success
f aneurysm exclusion. With increased experience and im-
rovements with this imaging modality, it may be possible
o ultimately supplant follow-up MDCT, at least in the
hort-term period. The use of CBCT, however, is not
ithout its limitations. First, it is limited by the fixed area
vailable for scanning. For instance, DynaCT (Siemens
ealthcare) is limited by a maximum of 18-cm scanning
istance in the z-axis, thus, in cases in which a long length
f aorta is covered with a stent graft, the entire treatment
rea would not be imaged by CBCT. In addition, imaging
rtifacts were identified in 10% of the CBCT scans per-
ormed. Other problems include difficulty with contrast
ifferentiations, particularly in areas of low radiographic
ontrast.11 Of some concern is the additional radiation
ose provided by CBCT, particularly if two applications of
his technology are performed during one operation. The
adiation dose for a 14-second acquisition is similar to that
f a biplane digital subtraction acquisition during a routine
erebral angiogram.12 Radiation dose, however, is higher
n CBCT (236 mGy) compared to traditional 3D-DSA
ith a standard image intensifier (50 mGy).11 A compari-
on between the CBCT and MDCT in terms of radiation
xposure is complicated by a lack of a universally accepted
ommon dose metric. Previous experiments done using
BCT demonstrated a lower radiation dose compared to
ingle helical CT, however in this experiment, contrast and
patial resolution were inferior to MDCT.10 Eide et al
eported radiation doses to be comparable between these
odalities, but effective dose was calculated using a con-
R1
1
1
1
1
JOURNAL OF VASCULAR SURGERY
March 2011590 Dijkstra et alversion factor to overcome some of the differences that
cannot be directly measured.13 Estimates of radiation dos-
ages in this article are derived from unpublished data sup-
plied by Siemens Healthcare. These data suggest CBCT
radiation dosage to be comparable or slightly higher com-
pared with MDCT. Internal Alderson phantom measure-
ments by Siemens report an estimated dose of 11 mSv for
the 8sDR. The 5sDR protocol was not tested. An estimate
derived from the values for the 8sDR would be roughly 11
mSv * (133/397)  4 mSv. In comparison, literature
reports an average estimated dose for completion aortog-
raphy of 12 mSv (values reported 4.0-48.0) and 8 mSv
(values reported 3.5-25) for abdominal MDCT.14
CBCT is a valuable addition to the endovascular suite
and the treatment of complex and routine aortic diseases.
In the preprocedural setting, it can be used to identify
pathology and accurately plan treatment. Its use intraoper-
atively to guide the accurate placement of endovascular
devices results in lower contrast doses and may ultimately
reduce operative and fluoroscopy times. This will improve
overall safety for both patients and surgeon. Lastly, CBCT
appears to identify success of repair as readily as follow-up
MDCT. Its use intraoperatively may reduce subsequent
rates of reintervention following procedures such as FE-
VAR, but this has yet to be shown. Further studies evalu-
ating a larger number of patients could potentially demon-
strate the valuable nature of this technology in evolution.
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